ALTANA underwent dynamic developments in the recent past. Following the divestment of the ALTANA Pharma Division, the company was publicly traded as a corporation with focus on specialty chemicals until mid-2010. The shareholders' meeting resolved on June 30, 2010 to transfer all shares of the company to the majority shareholder SKion GmbH, a holding company of Susanne Klatten. This ended the public trading of ALTANA stock.

The new ownership structure provides ALTANA with excellent conditions for responding to entrepreneurial opportunities swiftly and flexibly, while continuing to follow its successful pathway of profitable growth.